Popular Stories

Patients Tag

  • All
  • Biotechnology
  • Cannabis
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Otonomy Enters Strategic Collaboration with AGTC to develop a novel Gene Therapy for Congenital Hearing Loss

Otonomy Inc (NASDAQ: OTIC), a biopharmaceutical company focussed on providing neurotology solutions, announced a strategic collaboration with Applied Genetic Technologies Corporation (NASDAQ: AGTC), a biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, to create, develop and commercialize an AAV-based...

Top 5 Emerging Therapeutics for Crigler – Najjar Syndrome

Crigler Najjar Syndrome, also called hyperbilirubinemia, is a chronic condition characterized by high levels of unconjugated bilirubin in the blood. The disease manifests as Jaundice at birth, and can progressively lead to kernicterus, a condition in which the accumulation of unconjugated bilirubin can damage brain...

ReWalk Raises $5M for its ReStore Exosuit for Stroke Victims

Standing Tall ReWalk Robotics (NASDAQ: RWLK) recently received an approval for its ReStore exoskeleton system, indicated for rehabilitation of stroke victims, from the FDA. The company also manufactures ReWalk robotic exoskeleton, the first to receive FDA approval for personal and rehabilitation use in the United States. It...

WordPress Video Lightbox Plugin